Assertio Stock Presents High-Risk, High-Reward Opportunity As Company Transforms Business

The article mentions Assertio Holdings (NASDAQ:ASRT) as the stock being discussed. The author gives a strong buy rating for Assertio, stating that the stock could double in value. The core argument of the article is that Assertio has faced challenges in the past but has shown resilience and is now in a better financial position for future growth. Key information and data provided include Assertio's diverse pharmaceutical portfolio, its recent financial performance and its acquisition of Spectrum. The article also highlights the risks that Assertio faces, such as generic competition, market uncertainty, and legal liabilities.